Name | N-[6-(1H-Imidazol-1-yl)imidazo[1,2-a]pyridin-2-yl]-4-(2-methyl-2-propanyl)benzamide dihydrochloride |
---|---|
Synonyms |
N-[6-(1H-Imidazol-1-yl)imidazo[1,2-a]pyridin-2-yl]-4-(2-methyl-2-propanyl)benzamide dihydrochloride
Benzamide, 4-(1,1-dimethylethyl)-N-[6-(1H-imidazol-1-yl)imidazo[1,2-a]pyridin-2-yl]-, hydrochloride (1:2) TCASK10 |
Description | TC ASK 10 (Compound 10) is a potent, selective and orally active apoptosis signal-regulating kinase 1 (ASK1) inhibitor with an IC50 of 14 nM. The inhibitory activities of TC ASK 10 towards other representative panel of kinases are less than 50%, except for ASK2 (IC50 of 0.51 μM)[1]. |
---|---|
Related Catalog | |
Target |
ASK1:14 nM (IC50) |
In Vitro | TC ASK 10 (Compound 10; 0-10 μM; 1 hour; INS-1 cells) treatment inhibits streptozotocin (STZ)-induced JNK in INS-1 pancreatic β cells from 0.3 μM. Phosphorylation of p38 is also inhibited in a dosedependent manner[1]. Western Blot Analysis[1] Cell Line: INS-1 cells Concentration: 0 μM, 0.3 μM, 1 μM, 3 μM, 10 μM Incubation Time: 1 hour Result: Was found to inhibit streptozotocin (STZ)-induced JNK in INS-1 pancreatic β cells from 0.3 μM. Phosphorylation of p38 was also inhibited in a dosedependent manner. |
In Vivo | Pharmacokinetic profiles in rats are tested. TC ASK 10 (Compound 10•HCl; rat cassette doing at 0.1 mg/kg, iv and 1 mg/kg, po.) has a good oral bioavailability. The Cmax, Tmax and AUCpo,0-8h are 285.1 ng/mL, 1.67 h and 275.4 ng.h/mL, respectively for TC ASK 10[1]. |
References |
Molecular Formula | C21H23Cl2N5O |
---|---|
Molecular Weight | 432.346 |
Exact Mass | 431.127960 |
Hazard Codes | Xi |
---|